These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28168205)

  • 41. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population.
    Dou Q; Peng Y; Zhou B; Zhang K; Lin J; Dai X; Zhang L; Rao L
    Int J Mol Sci; 2015 Sep; 16(9):22299-318. PubMed ID: 26389889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visfatin, low-grade inflammation and body mass index (BMI).
    Samara A; Pfister M; Marie B; Visvikis-Siest S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating blood eNAMPT drives the circadian rhythms in locomotor activity and energy expenditure.
    Park JW; Roh E; Kang GM; Gil SY; Kim HK; Lee CH; Jang WH; Park SE; Moon SY; Kim SJ; Jeong SY; Park CB; Lim HS; Oh YR; Jung HN; Kwon O; Youn BS; Son GH; Min SH; Kim MS
    Nat Commun; 2023 Apr; 14(1):1994. PubMed ID: 37031230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The expression of nicotinamide phosphoribosyl transferase and vascular endothelial growth factor-A in gastric carcinoma and their clinical significance].
    Long HL; Che XM; Bi TQ; Li HJ; Liu JS; Li DW
    Zhonghua Wai Ke Za Zhi; 2012 Sep; 50(9):839-42. PubMed ID: 23157963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visfatin/Nampt and SIRT1: Roles in Postterm Delivery in Pregnancies Associated With Obesity.
    Tsai PJ; Davis J; Thompson K; Bryant-Greenwood G
    Reprod Sci; 2015 Aug; 22(8):1028-36. PubMed ID: 25670718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of visceral adiposity with oesophageal and junctional adenocarcinomas.
    Beddy P; Howard J; McMahon C; Knox M; de Blacam C; Ravi N; Reynolds JV; Keogan MT
    Br J Surg; 2010 Jul; 97(7):1028-34. PubMed ID: 20632268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects.
    Hashimoto I; Wada J; Hida A; Baba M; Miyatake N; Eguchi J; Shikata K; Makino H
    Obesity (Silver Spring); 2006 May; 14(5):799-811. PubMed ID: 16855189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.
    Mokrowiecka A; Daniel P; Jasinska A; Pietruczuk M; Pawlowski M; Szczesniak P; Orszulak-Michalak D; Malecka-Panas E
    Hepatogastroenterology; 2012; 59(120):2395-9. PubMed ID: 22944288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic value of metastatic lymph node ratio in adenocarcinoma of the gastroesophageal junction].
    Zhang HD; Ma Z; Tang P; Duan XF; Ren P; Yue J; Yu ZT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):822-6. PubMed ID: 24061985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer.
    Travelli C; Colombo G; Aliotta M; Fagiani F; Fava N; De Sanctis R; Grolla AA; Garcia JGN; Clemente N; Portararo P; Costanza M; Condorelli F; Colombo MP; Sangaletti S; Genazzani AA
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37880182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of body mass index and visceral adiposity on outcomes in colorectal cancer.
    Yamamoto N; Fujii S; Sato T; Oshima T; Rino Y; Kunisaki C; Masuda M; Imada T
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):337-45. PubMed ID: 22897609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotinamide phosphoribosyltransferase/pre-B-cell colony enhancing factor/visfatin plasma levels and clinical outcome in patients with dilated cardiomyopathy.
    Bobbert P; Kühl U; Poller W; Rauch U; Schultheiss HP; Skurk C
    J Card Fail; 2015 Apr; 21(4):330-8. PubMed ID: 25498756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A high-fat diet is associated with altered adipokine production and a more aggressive esophageal adenocarcinoma phenotype in vivo.
    Fowler AJ; Richer AL; Bremner RM; Inge LJ
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1185-91. PubMed ID: 25595377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.
    Zhou Z; Zhang H; Xu Z; Li W; Dang C; Song Y
    World J Surg Oncol; 2015 Jun; 13():197. PubMed ID: 26055624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nicotinamide phosphoribosyltransferase in malignancy: a review.
    Shackelford RE; Mayhall K; Maxwell NM; Kandil E; Coppola D
    Genes Cancer; 2013 Nov; 4(11-12):447-56. PubMed ID: 24386506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor.
    Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Shigaki H; Yamaguchi T
    Ann Surg Oncol; 2014 May; 21(5):1596-601. PubMed ID: 24531703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic implications of visceral obesity on gastric adenocarcinoma: does it really matter?
    Gürsoy Çoruh A; Uzun Ç; Akkaya Z; Avcı O; Adıgüzel M; Ersöz CC; Elhan AH
    Clin Imaging; 2021 Aug; 76():228-234. PubMed ID: 33971589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.